Found 81 matching trials
A Phase 1b/2 Clinical Trial to Evaluate the Safety and Efficacy of ConvitVax in Metastatic Breast Cancer
PHASE1This is a proof-of-concept, single-center, non-randomized, open-label, phas...
Location
Jacinto Convit World Organization, Inc.
Personalized Neoantigen Peptide Vaccines for Solid Tumors
PHASE1This clinical trial is studying the safety and efficacy of a personalized c...
Location
Horizon Cancer Excellence Center, Bumrungrad International Hospital
Optimizing Cellular and Humoral Immunity by Vaccinating With PCV13 Before and After CAR-T Therapy
PHASE2The purpose of the study is to evaluate whether receiving the pneumococcal ...
Status
Active Not Recruiting
Location
Moffitt Cancer Center
Personalized DC Vaccine for Postoperative Cancer
PHASE1The study is aimed to the test efficacy and safety of neoantigen-primed den...
Proteome-based Immunotherapy of Brain Metastases From Breast Cancer
PHASE2Trial Hypothesis: Acute, progressing lethal neurooncological process can be...
Location
ZAO "NeuroVita Clinic of Interventional and Restorative Neurology and Therapy"
Personalized Cellular Vaccine for Glioblastoma (PERCELLVAC)
PHASE1Dendritic cell-based cellular vaccine for tumor therapy has shown efficacy....
Location
Guangdong 999 Brain Hospital
Clinical Study of Novel Therapeutic Vaccine for Advanced Solid Tumors
PHASE1Advanced solid tumors remain a major therapeutic challenge due to their com...
Location
West China Hospital, Sichuan University
Autologous Neoantigen-Specific T-Cell Therapy for Advanced Hepatocellular Carcinoma
PHASE1The goal of this open-label, single-arm phase I/II clinical trial is to eva...
Location
The First Affiliated Hospital, Zhejiang University School of Medicine
Safety and Efficacy Study for DC Vaccine in Recurrent or Progressive High-grade Gliomas
PHASE1This is a single-center, open-label, multi-dose phase I clinical trial eval...
Location
Beijing Tiantan Hospital, Capital Medical University
PEP-DC and OC-DC Vaccine in High Grade Serous Ovarian Carcinoma
PHASE1Single center, phase I/II randomized 2-arm study, evaluating two different ...
Location
Multiple Locations